Matching mutations to immunotherapy response – Nature.com
|
Matching mutations to immunotherapy response
Nature.com The presence of mismatch repair (MMR) deficiency could be used as a predictor of response of solid tumours to PD-1 (programmed cell death protein 1) blockade immunotherapy, according to a report published in Science. The clinical trial, which is still … |
